Burzynski Resh Inst (BZYR) Stock Price, News & Analysis
Company Description
Burzynski Resh Inst (OTC Link: BZYR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $525.8K.
BZYR stock has declined 85.3% over the past year. Shares last traded at $0.0050.
On a trailing twelve-month basis, Burzynski Resh Inst reported revenue of $0 and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of BZYR stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Burzynski Resh Inst (BZYR) stock last traded at $0.0050, up 25.00% from the previous close. Over the past 12 months, the stock has lost 85.3%. At a market capitalization of $525.8K, BZYR is classified as a micro-cap stock with approximately 131.4M shares outstanding.
BZYR Rankings
Latest News
SEC Filings
Burzynski Resh Inst has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form 10-Q, 1 Form 8-K/A. The most recent filing was submitted on May 12, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BZYR SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.01.
Upcoming Events
Short Interest History
Short interest in Burzynski Resh Inst (BZYR) currently stands at 285 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 83.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Burzynski Resh Inst (BZYR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BZYR Company Profile & Sector Positioning
Burzynski Resh Inst (BZYR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.